Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02603289 · ClinicalTrials.gov registry record
One Week Aligner Evaluation
A clinical trial, sponsored by Align Technology.
- Completed
- Registry status
- 287
- Enrollment target
NCT02603289: Completed study, sponsored by Align Technology.
NCT02603289 is a clinical trial that has completed, run by Align Technology. The registered enrollment target is 287 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02603289 has completed, sponsored by Align Technology.
- COMPLETED
- Registry status
- 287 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that changing aligners weekly provides similar results to changing aligners every two weeks.
Primary Outcome
Test vs Historical Control Group
Interventions
- DEVICE Invisalign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2015-09 |
| Est. Completion | 2020-08 |
What the finished NCT02603289 record still lists
NCT02603289 is an observational study that tracks outcomes without assigning an intervention. The registered 287 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Invisalign is the first listed.
NCT02603289 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02603289 about?
NCT02603289 is a clinical study titled "One Week Aligner Evaluation". The purpose of this study is to demonstrate that changing aligners weekly provides similar results to changing aligners every two weeks.
What is the current status of trial NCT02603289?
This trial is currently completed. The enrollment target is 287 participants. The study started on 2015-09. Estimated completion is 2020-08.
What interventions are being tested in trial NCT02603289?
The interventions under investigation include: Invisalign (DEVICE).
Who is sponsoring clinical trial NCT02603289?
This trial is sponsored by Align Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03094429 · 287 participants · Phase 2
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
- NCT06385080 · 287 participants · Phase 1
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- NCT06919224 · 287 participants · NA
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia